6 citations
,
August 2016 in “Journal of women & aging” This study found that women with negative or mixed feelings about Botox and facial fillers reported diverse and sometimes persistent physical and psychological impacts, feeling commodified, fractured, abandoned, reflective, and transformed.
December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” This study found that androgenetic alopecia in men is associated with significant psychological distress and moderate depression, suggesting a possible link between raised dihydrotestosterone levels and mental health issues.
November 2025 in “Frontiers in Pharmacology” This pharmacovigilance study identified 64 drugs linked to hair loss, revealing specific demographic trends and timing patterns, and emphasized the importance of gender-specific monitoring and label updates to better convey real-world risks.
November 2025 in “Open Repository of the University of Porto (University of Porto)” This report reviews a pharmacy internship experience, presenting activities and two scientific topics, but does not report new research findings.
November 2024 in “Open Repository of the University of Porto (University of Porto)” Tailored medication preparation and ongoing education are crucial for effective treatments.
November 2023 in “Open Repository of the University of Porto (University of Porto)” This summary of a pharmacy internship reports on expanding scientific knowledge through diverse activities, including exploring diabetes medications for obesity treatment and discussing the role of nutritional supplements in geriatrics.
October 2023 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in patient care and optimizing treatment outcomes.
This review suggests that finasteride at 1 mg/day reduces PSA levels similarly to 5 mg/day, but differences in prostate dihydrotestosterone levels may affect prostate cancer diagnosis and prevention.
1 citations
,
June 2023 in “PubMed” September 2024 in “Journal of the American Academy of Dermatology” Organizations help patients access discounts for expensive dermatology medications.
November 2025 in “Urology” This study found that the Mark Cuban Cost Plus Drug Company offers significant cost savings on men's health medications compared to both Medicare and GoodRx, particularly for erectile dysfunction treatments.
24 citations
,
December 2016 in “Psychiatric Clinics of North America” This review discusses hormonal and surgical gender-affirming interventions for transfeminine individuals, noting improvements in quality of life and mental health with minimal adverse effects, but reports no new research findings.
4 citations
,
March 2008 in “Advances in Chronic Kidney Disease” This article discusses the challenges ESRD patients face with Medicare Part D, including high out-of-pocket costs and coverage gaps, but reports no new research data.
1 citations
,
February 2011 in “VTechWorks (Virginia Tech)” This thesis explored the relationship between wholesale and retail prescription drug prices and concluded that unexpected negative mark-ups and inaccurate wholesale price comparisons suggest further investigation is needed.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.
This article describes a soap bar infused with essential oils for hair and body care, but it reports no new research findings.
4 citations
,
January 2016 in “Digital Scholarship - UNLV (University of Nevada Reno)” This study found that ethnic and racial differences in dermatology service use in the U.S. may stem from patient preferences or insurance coverage policies rather than clinical needs.
3 citations
,
September 2020 in “Cancer Prevention Research” This study found that health insurance mandates following the Affordable Care Act increased colorectal cancer screening rates by 2.8 percentage points among U.S. adults aged 50 to 74.
6 citations
,
February 2023 in “International Journal of Women’s Dermatology” This study found that insurance coverage for cranial hair prostheses in patients with alopecia areata is generally inadequate, adding to their financial and psychological burdens.
2 citations
,
February 2023 in “Journal of the American Academy of Dermatology” This study observed that patients with autism spectrum disorder have a higher risk of developing alopecia areata compared to those without ASD, suggesting a possible link between the two conditions.
1 citations
,
August 2013 in “Journal of Clinical Epidemiology” This narrative review discusses various epidemiological study designs, the importance of reliable bias assessment tools, and the implications of database use for hypothesis testing in different research areas; it reports no new results.
July 2026 in “Journal of the American Academy of Dermatology” Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.
November 2025 in “The Journal of Sexual Medicine” This study found that the Mark Cuban Cost Plus Drug Company model offers substantial cost savings on men's health medications compared to Medicare and GoodRx, particularly for long-term treatments.
October 2025 in “Infection Control and Hospital Epidemiology” This article discusses developing a standardized operating procedure for PRP administration to align with infection prevention regulatory standards and reports no new clinical results.
March 2016 in “Oncology Times” This article reviews the challenges and differing perspectives on implementing cancer care pathways, highlighting an ASCO task force's recommendation for flexibility that met resistance due to administrative burdens and regional variations.
1 citations
,
November 2021 in “World Family Medicine Journal /Middle East Journal of Family Medicine” This study aims to determine if an integrated early childhood development package can reduce developmental delays among two-year-old children in public health centers in Pakistan.
June 2025 in “Transgender Health” This review discusses the current limitations in insurance coverage and access to facial masculinization surgery in the US and suggests that expanding insurance policies may help reduce care inequities.
September 2018 in “Boletín médico del Hospital Infantil de México” This article examines the care and health challenges faced by transgender or gender incongruence individuals, reporting no new clinical results; it highlights the importance of an individualized approach for optimizing well-being.
This study observed that combining PRP and Tressfix Serum significantly improved hair regrowth and reduced microRNA expression linked to Chronic Telogen Effluvium compared to using either treatment alone.
July 2023 in “Australasian Journal of Dermatology” This study described the incidence and prevalence of alopecia areata in Australia's primary healthcare population, finding the highest incidence in individuals aged 19 to 34, with males more affected than females.